Cannabinol Use in Patients With Insomnia Disorder

NCT05344170 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Insomnia Disorder

Interventions

DRUG: 30 mg Cannabinol (CBN)
DRUG: 300 mg Cannabinol (CBN)
DRUG: Placebo

Sponsor

Woolcock Institute of Medical Research

Collaborators

[object Object]